These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Is short-course treatment an option for community-acquired pneumonia?]. Petitpretz P Med Mal Infect; 2008 Jun; 38 Suppl 2():S106-7. PubMed ID: 18598857 [No Abstract] [Full Text] [Related]
23. [Can macrolide treatment delay the diagnosis of tuberculosis?]. Gómez Cubillos C; Carrión Valero F; Pascual Izuel JM An Med Interna; 1999 Jul; 16(7):385-6. PubMed ID: 10481348 [No Abstract] [Full Text] [Related]
24. Inappropriate fluoroquinolone use resulting from lack of specific guidelines. Luh JY; Karnath BM Arch Intern Med; 2003 Sep; 163(16):1978. PubMed ID: 12963575 [No Abstract] [Full Text] [Related]
25. [The usefulness of the new prognostic classifications in the treatment of community acquired pneumonia]. Gudiol F Med Clin (Barc); 1998 Feb; 110 Suppl 1():77-8. PubMed ID: 9717166 [No Abstract] [Full Text] [Related]
26. Drug not considered a first-line agent. Lexchin J Can Fam Physician; 1998 Nov; 44():2376. PubMed ID: 9839049 [No Abstract] [Full Text] [Related]
27. [The role of "respiratory" fluoroquinolones in current antibacterial treatment of extrahospital pneumonia]. Sinopal'nikov AI Ter Arkh; 2002; 74(4):80-5. PubMed ID: 12043253 [No Abstract] [Full Text] [Related]
28. To give or not to give antibiotics to children with pneumonia. Ferrero F; Nascimento-Carvalho CM Pediatr Emerg Care; 2010 Nov; 26(11):870. PubMed ID: 21057289 [No Abstract] [Full Text] [Related]
29. [Initial treatment can lighten low-severity community-acquired pneumonia]. Wasielewski S Med Monatsschr Pharm; 2005 Nov; 28(11):413. PubMed ID: 16309029 [No Abstract] [Full Text] [Related]
30. At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia. Daneman N; Low DE; McGeer A; Green KA; Fisman DN Clin Infect Dis; 2008 Apr; 46(8):1131-8. PubMed ID: 18444846 [TBL] [Abstract][Full Text] [Related]
31. Community acquired pneumonia. Sargeant P Aust Fam Physician; 2004 Aug; 33(8):583; author reply 583. PubMed ID: 15373373 [No Abstract] [Full Text] [Related]
32. Tsukamurella infection: a rare cause of community-acquired pneumonia. Mehta YB; Goswami R; Bhanot N; Mehta Z; Simonelli P Am J Med Sci; 2011 Jun; 341(6):500-3. PubMed ID: 21613935 [TBL] [Abstract][Full Text] [Related]
36. Community-acquired pneumonia: the U.S. perspective. Niederman MS Semin Respir Crit Care Med; 2009 Apr; 30(2):179-88. PubMed ID: 19296418 [TBL] [Abstract][Full Text] [Related]
37. Fluoroquinolones may delay the diagnosis of tuberculosis. Ang D; Hsu AA; Tan BH Singapore Med J; 2006 Sep; 47(9):747-51. PubMed ID: 16924354 [TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolone use delays tuberculosis treatment despite immediate mycobacteriology study. Wang JY; Lee CH; Yu MC; Lee MC; Lee LN; Wang JT Eur Respir J; 2015 Aug; 46(2):567-70. PubMed ID: 25900374 [No Abstract] [Full Text] [Related]
39. The United States guidelines for the management of community-acquired pneumonia and their relevance to Australasia. Waterer GW; Grayson ML Intern Med J; 2007 Dec; 37(12):789-91. PubMed ID: 18028080 [No Abstract] [Full Text] [Related]